Bristol Myers Squibb/LinkedIn
Nov 6, 2023, 17:40
Chris Boerner begins his new role as Bristol Myers Squibb CEO
Quoting Bristol Myers Squibb on LinkedIn;
“Today Chris Boerner begins his new role as our CEO and on April 1, 2024, he’ll succeed Giovanni Caforio as Chair of the Board of Directors. With over eight years’ experience at BMS leading growth and innovation across the company’s key franchises, he ushers in a new era for our global team. Learn more here.”
Source: Bristol Myers Squibb/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 04:25
Sep 6, 2025, 21:28
Sep 6, 2025, 20:34
Sep 6, 2025, 20:20
Sep 6, 2025, 20:00
Sep 6, 2025, 19:13
Sep 6, 2025, 19:01